Clinical Trials Directory

Trials / Completed

CompletedNCT00430053

Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma

Pathogenesis And Course Of Cutaneous T-Cell Lymphoma

Status
Completed
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
National Institutes of Health Clinical Center (CC) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Gathering information about patients with cutaneous T-cell lymphoma over time may help doctors learn more about the disease. PURPOSE: This natural history study is collecting disease-related health information over time from patients with cutaneous T-cell lymphoma.

Detailed description

OBJECTIVES: Primary * Follow the disease course of patients with cutaneous T-cell lymphoma. * Provide a patient population for study by proteomic and molecular analysis. * Develop a mechanism for screening by a Tumor Board for enrollment of patients in therapeutic clinical trials. Secondary * Develop a tissue bank for future disease study using specimens from these patients. * Provide community outreach by offering a second opinion regarding treatment of this disease in these patients and, in limited cases, provide standard-of-care treatment to these patients. * Develop an algorithm for screening and evaluating this disease in these patients. OUTLINE: Patients undergo disease assessment by physical examination, full-body photographic documentation of skin disease, biopsy, and blood sampling at baseline and then at least annually thereafter. Proteomic and molecular methods are used to analyze samples. Biopsies may be examined using histologic and immunohistochemical methods. Blood may be analyzed by polymerase chain reaction for clonal T-cell gene rearrangements or by flow cytometry. PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study within 5 years.

Conditions

Interventions

TypeNameDescription
GENETICgene rearrangement analysis
GENETICpolymerase chain reaction
GENETICproteomic profiling
OTHERflow cytometry
OTHERimmunohistochemistry staining method
PROCEDUREbiopsy

Timeline

Start date
2004-01-01
Completion
2010-06-01
First posted
2007-02-01
Last updated
2012-03-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00430053. Inclusion in this directory is not an endorsement.